MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis
about
Epigenetic Regulation of Epidermal Stem Cell Biomarkers and Their Role in Wound HealingmiRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agentsComprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.Regulation of cancer metastasis by microRNAs.RETRACTED: Role of microRNA 30a targeting insulin receptor substrate 2 in colorectal tumorigenesis.Role of microRNA-30c targeting ADAM19 in colorectal cancer.SEMA6D Expression and Patient Survival in Breast Invasive CarcinomaMiRNA-149 modulates chemosensitivity of ovarian cancer A2780 cells to paclitaxel by targeting MyD88miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets.MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5.MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cellsPre-miR-149 rs71428439 polymorphism is associated with increased cancer risk and AKT1/cyclinD1 signaling in hepatocellular carcinoma.GIT1 is a novel prognostic biomarker and facilitates tumor progression via activating ERK/MMP9 signaling in hepatocellular carcinomamiR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1FGIT1 promotes lung cancer cell metastasis through modulating Rac1/Cdc42 activity and is associated with poor prognosis.MicroRNA-34c Suppresses Breast Cancer Migration and Invasion by Targeting GIT1.18β-glycyrrhetinic acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1 signaling.MiR-138: A promising therapeutic target for cancer.MicroRNA-149 targets specificity protein 1 to suppress human tongue squamous cell carcinoma cell proliferation and motility.Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma.MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4CArf proteins in cancer cell migration.Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.MeCP2, a target of miR-638, facilitates gastric cancer cell proliferation through activation of the MEK1/2-ERK1/2 signaling pathway by upregulating GIT1.miR-125a-3p targetedly regulates GIT1 expression to inhibit osteoblastic proliferation and differentiation.Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.Methylation-regulated miR-149 modulates chemoresistance by targeting GlcNAc N-deacetylase/N-sulfotransferase-1 in human breast cancer.Cool-associated Tyrosine-phosphorylated Protein 1 Is Required for the Anchorage-independent Growth of Cervical Carcinoma Cells by Binding Paxillin and Promoting AKT Activation.G-Protein-Coupled Receptor-2-Interacting Protein-1 Controls Stalk Cell Fate by Inhibiting Delta-like 4-Notch1 Signaling.Targeting of GIT1 by miR-149* in breast cancer suppresses cell proliferation and metastasis in vitro and tumor growth in vivo.The Arf-GAP and protein scaffold Cat1/Git1 as a multifaceted regulator of cancer progression.miR-149 in Human Cancer: A Systemic Review.Differential microRNA expression in breast cancer with different onset age.miR‑149‑5p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathway.The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets.ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients.MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.The clinicopathological significance of miR-149 and PARP-2 in hepatocellular carcinoma and their roles in chemo/radiotherapy.Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells.MicroRNA-33a downregulation is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma.
P2860
Q26771827-677D5192-CD46-45BB-AB5A-31F3F96AC9FDQ27023295-D0E945AE-143D-4AEE-8320-E9D63C581DB4Q34630091-A01533D4-D78B-4427-9ED1-8E61F9AFEFAEQ35052860-9039634C-0196-4F1C-8155-5E03D3562B0EQ35097075-997C6AE2-68BF-4C7D-8B51-F568507D8B29Q35208955-FE3E996B-5CEB-4AB1-A1F9-3E5CB8566777Q35564103-00AB4481-B46F-4E4E-91E8-439FE9D651E5Q35902797-E9CD9361-487A-4CFE-8728-7B6EFAD06236Q35912303-00DC871C-9E50-443F-A250-2960106A17F0Q35955237-4BB6A61D-A229-4066-A87D-935B98BE01D9Q35955244-2EEA87AF-8962-42B7-94E8-7609C45ED344Q36183193-67297B08-CC5E-4CA2-8107-5734B5390910Q36399068-D85949E1-BA5D-4A02-BFC6-E100E85924C8Q36545884-1210D22D-DFE8-4E68-A484-22E0A4F7B121Q36546633-7EDF4167-DDAA-465E-878D-7D53B9A7E3A1Q37290547-41CC4CE0-ED12-4002-92E8-C03202893C4DQ37687747-9EEDEE60-EF6C-4E8F-AF15-6FE0DC9EAF72Q38734800-4327FD91-260C-4C2F-8B2A-F34EE2481F00Q38737855-AA6FF67B-8D02-4565-8095-047C9D99DF70Q38807433-BA3C42FF-E57A-4F13-9EA1-9556D530BBF2Q38842997-17B3EED0-B9F2-49A3-989E-12B343FAE0D7Q38944847-E6055CB7-6A67-4B86-8FD4-11062BB6604FQ38958559-0F3D42E8-87F8-44EF-9B46-DE85723E630BQ41228798-D2DDE3B8-F424-4CFB-8637-6803C37A644FQ41397045-23ECB354-EE8E-485B-8CA9-18D5201BF95CQ41660592-09AB9A73-6D79-476B-AB66-3F57FDE87D0EQ42464523-61B39C79-A441-42C5-AB34-5D3D4FDDD5E3Q42803641-08935DBC-4457-4CD2-8267-430325CCBAA5Q46197608-EE2F7B9E-0339-4A1B-8867-621D0AC3CD8EQ47137266-EF7BDF75-CD4C-4091-BD33-32DF5F65AEBFQ47693046-95EEE7AB-7B6A-4A07-AFD6-845C04E2ECC2Q47726472-6BFC3FA6-F90D-467D-8C61-B94852D73DD2Q48259419-3C26DACF-7153-402E-BF2D-CF0F15DB5613Q49379529-52430A2F-A20E-4DA2-91AF-401D27A0A03CQ49593660-57E18204-319D-42C1-A31B-93F5F13A8E49Q50534879-6AD5DA8C-26FC-452B-B3D9-FBD456C96D6FQ50916076-2ED63A7B-D8CC-4AE7-B3AE-D905E52BD4CFQ51703634-A68B1FD2-CE21-4019-9638-F169B8F05A5DQ52641750-DE13CB66-3B19-43A3-AC12-4597875A84A4Q52655136-347FEC6C-0A88-4745-929F-4CD35AA82526
P2860
MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis
@ast
MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis
@en
MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis
@nl
type
label
MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis
@ast
MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis
@en
MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis
@nl
prefLabel
MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis
@ast
MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis
@en
MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis
@nl
P2093
P2860
P356
P1433
P1476
MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2014.10
P407
P577
2014-03-10T00:00:00Z
P5875
P6179
1025882454